In conclusion, the peripheral blood of patients with SLE contains activated CD8+ T cells, which are associated with disease activity and renal, haematological and other organ involvement (especially active lupus nephritis) and may be a potential predictor of residual immune abnormalities and difficulty in reducing therapeutic drug doses after treatment. Here, CD8A is linked to lupus nephritis.